MED10 and bladder transitional cell carcinoma: Reaffirming previous data, we demonstrated similarity in the cancer-normal differential expression profile of MED10 (fold change, FC = 1.76, p = 5.7e-06) and hsa-miR-590-5p (FC = 5.78, p = 1.4e-30) in the TCGA BLCA cohort (Figures 5A, B).